Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichiro Irie

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Autoimmunity|December 17, 2008
FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese, especially in women and slowly progressive-type patientsKyoko Iwase, Akira Shimada, Toshihide Kawai, et al.
Primary Care Diabetes|December 3, 2014
Relationships among different glycemic variability indices obtained by continuous glucose monitoringYoshifumi Saisho, Chihiro Tanaka, Kumiko Tanaka, et al.
Clinical Drug Investigation|December 28, 2010
Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label studyToshihide Kawai, Izumi Takei, Akira Shimada, et al.
Autoimmunity|December 29, 2004
Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD miceKeiichi Kodama, Akira Shimada, Osamu Funae, et al.
Endocrinology|April 30, 2014
The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male miceTaichi Sugizaki, Mitsuhiro Watanabe, Yasushi Horai, et al.
Clinical Drug Investigation|September 16, 2015
Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized TrialKumiko Tanaka, Yoshifumi Saisho, Erica Manesso, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2020
Contribution of uremic dysbiosis to insulin resistance and sarcopeniaKiyotaka Uchiyama, Shu Wakino, Junichiro Irie, et al.
Nutrients|April 27, 2018
Efficacy of a Moderately Low Carbohydrate Diet in a 36-Month Observational Study of Japanese Patients with Type 2 DiabetesMariko Sanada, Chinatsu Kabe, Hisa Hata, et al.
Plos One|October 4, 2023
Assessment of glycemic variability and lifestyle behaviors in healthy nondiabetic individuals according to the categories of body mass indexKazuhiro Kashiwagi, Jun Inaishi, Shotaro Kinoshita, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditionsJunki Miyamoto, Ryuji Ohue-Kitano, Hiromi Mukouyama, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Autoimmunity|December 17, 2008
FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese, especially in women and slowly progressive-type patientsKyoko Iwase, Akira Shimada, Toshihide Kawai, et al.
Primary Care Diabetes|December 3, 2014
Relationships among different glycemic variability indices obtained by continuous glucose monitoringYoshifumi Saisho, Chihiro Tanaka, Kumiko Tanaka, et al.
Clinical Drug Investigation|December 28, 2010
Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label studyToshihide Kawai, Izumi Takei, Akira Shimada, et al.
Autoimmunity|December 29, 2004
Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD miceKeiichi Kodama, Akira Shimada, Osamu Funae, et al.
Endocrinology|April 30, 2014
The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male miceTaichi Sugizaki, Mitsuhiro Watanabe, Yasushi Horai, et al.
Clinical Drug Investigation|September 16, 2015
Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized TrialKumiko Tanaka, Yoshifumi Saisho, Erica Manesso, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2020
Contribution of uremic dysbiosis to insulin resistance and sarcopeniaKiyotaka Uchiyama, Shu Wakino, Junichiro Irie, et al.
Nutrients|April 27, 2018
Efficacy of a Moderately Low Carbohydrate Diet in a 36-Month Observational Study of Japanese Patients with Type 2 DiabetesMariko Sanada, Chinatsu Kabe, Hisa Hata, et al.
Plos One|October 4, 2023
Assessment of glycemic variability and lifestyle behaviors in healthy nondiabetic individuals according to the categories of body mass indexKazuhiro Kashiwagi, Jun Inaishi, Shotaro Kinoshita, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditionsJunki Miyamoto, Ryuji Ohue-Kitano, Hiromi Mukouyama, et al.
Pageof 8